Unlalan, Choe .

HRN: 22-95-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/26/2023
05/03/2023
IVTT
350mg
Q8
Bacterial Skin Infection;URTI
Waiting Final Action 
04/26/2023
MUPIROCIN 2%, 15G (TUBE)
04/26/2023
05/03/2023
IVTT
2%
Q8
Bacterial Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: